Table 2.
Results of hemogram and biochemical series
| Pre-treatment | After 120 days of treatment | ||
|---|---|---|---|
| Blood count | Reference values | ||
| Red blood cells in millions | 9,93 | 8,12 | 5,5–8,5 u3 |
| Hemoglobin | 13,90 | 13,10 | 12,0–18,0 g/dL |
| Hematocrit | 43,60 | 38,70 | 37,0–55,0% |
| MCV | 43,90 | 47,66 | 60,0–77,0 fL |
| MCH | 13,99 | 16,13 | 19,0–23,0 pg |
| MCHC | 31,88 | 33,85 | 31,0–33,0 g/dL |
| RDW | 15,2 | 17,4 | 13,5–15,0% |
| Leucogram | |||
| Leukocytes | 15.300 | 6.700 | 6.000–17.000/mm3 |
| Rods | 306 | 134 | 0–300/mm3 |
| Segmented | 6.120 | 3.752 | 3.000–11.000/mm3 |
| Eosinophils | 459 | 268 | 100–1.250/mm3 |
| Lymphocytes | 7.497 | 2.345 | 1.000–4.800/mm3 |
| Monocytes | 918 | 201 | 150–1.350/mm3 |
| Platelets | 411.000 | 316.000 | 200.000–900.000 |
| Biochemistry | |||
| Oxalacetic transaminase | 28,0 | 27,0 | 26,0–43,0 U/L |
| Alkaline phosphatase | 15 | 13 | < 50 U/L |
| Bilirubin | |||
| Total bilirubin | 0,15 | 0,17 | 0–0,4 mg/dL |
| Indirect bilirubin | 0,05 | 0,08 | 0–0,1 mg/dL |
| Direct bilirubin | 0,06 | 0,09 | 0–0,3 mg/dL |
| Protein | |||
| Total proteins | 7,1 | 6,49 | 5,8–8,5 g/dl |
| Albumin | 3,5 | 3,11 | 1,9–3,80 g/dL |
| Globulins | 3,6 | 3,38 | 2,3–5,0 g/dL |
| Albumin/globulin ratio | 0,97 | 0,92 | 0,5–1,1 g/dL |
| Lipidogram | |||
| Total cholesterol | 123 | 179 | 95–130 mg/dL |
| HDL cholesterol | 43 | 63 | 42–58 mg/dL |
| LDL cholesterol | 73,2 | 106,2 | 69–94,9 mg/dL |
| VLDL cholesterol | 6,8 | 9,8 | 6–8 mg/dL |
| Triglycerides | 52 | 49 | 50–100 mg/dL |